Latest Financial Results News

Ironbark Capital reported an 8.4% portfolio return for FY25 and announced plans to rebrand and introduce quarterly dividends to address its persistent discount to net tangible assets.

Retail Food Group Limited demonstrated resilience in FY25 with slight sales growth and strategic expansions, setting a positive tone for FY26. Key brand innovations and franchisee support underpin its growth trajectory amid leadership transition.

Advanced Innergy Holdings Ltd (AIH) has reported FY25 unaudited proforma results that exceed its Prospectus forecasts, driven by strong demand in offshore wind and battery sectors. The recent acquisition of Ovun is integrating smoothly, with FY26 guidance reaffirmed.

Advanced Innergy Holdings Ltd (ASX – AIH) has completed its corporate restructure and ASX listing, reporting a 10% revenue increase and a strong £27.6 million adjusted EBITDA for FY25.

QBE Insurance Group reports sustained gross written premium growth of 6% for FY25 and announces a significant A$450 million on-market share buyback, reinforcing confidence in its financial outlook and capital management strategy.

New Zealand King Salmon reported an FY25 net loss driven by a shortened reporting period and biological challenges, while advancing its Blue Endeavour pilot project despite delays. The company projects a cautious recovery in FY26 with EBITDA guidance between NZD 9 million and 15 million.

New Zealand King Salmon Investments Limited has revealed a significant 44% decline in revenue alongside a net loss of NZD 6.3 million for the eight months ending September 2025, signaling challenges ahead for the seafood producer.

New Zealand King Salmon reports a $6.3 million net loss for an eight-month FY25 period, reflecting operational challenges and a shortened reporting cycle, while outlining cautious optimism for FY26 with targeted growth investments.

Ryman Healthcare reported a 13% revenue increase to NZD 413.8 million for H1 2025, yet swung to a significant net loss of NZD 45.2 million and suspended dividends, raising questions about its financial trajectory.

Ryman Healthcare reports a significant financial turnaround with its first positive free cash flow in over ten years, alongside upgraded sales and cost-saving targets for FY26 and completion of a major NZD 2 billion refinancing.

Ryman Healthcare has reported its first positive free cash flow in over a decade, driven by cost reductions and stronger sales momentum, while upgrading its sales guidance for FY26.

Tower Limited has reported a record underlying profit for FY25, driven by improved claims ratios, customer growth, and strategic initiatives including expanded risk-based pricing. The insurer declared increased dividends and outlined a positive growth outlook for FY26.